{
    "eid": "2-s2.0-85114394089",
    "title": "Population pharmacokinetics of meropenem in critically ill infant patients",
    "cover-date": "2021-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Critically ill",
        "Infants",
        "Meropenem",
        "Population pharmacokinetics"
    ],
    "authors": [
        "Wanlika Yonwises",
        "Noppadol Wacharachaisurapol",
        "Suvaporn Anugulruengkitt",
        "Passara Maimongkol",
        "Wanchai Treyaprasert"
    ],
    "citedby-count": 5,
    "ref-count": 27,
    "ref-list": [
        "Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients",
        "Paediatric pharmacokinetics: key considerations",
        "Pharmacokinetics of meropenem in critically ill patients with severe infections",
        "The effect of pathophysiology on pharmacokinetics in the critically ill patient\u2014concepts appraised by the example of antimicrobial agents",
        "Sequential, single-dose pharmacokinetic evaluation of meropenem in hospitalized infants and children",
        "Meropenem pharmacokinetics, pharmacodynamics, and Monte Carlo simulation in the neonate",
        "Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study",
        "A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection",
        "Population Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Critically Ill Young Children",
        "Optimization of meropenem dosage in the critically ill population based on renal function",
        "Population pharmacokinetics and pharmacodynamics of meropenem in pediatric patients",
        "Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies",
        "Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients",
        "Pharmacokinetics and pharmacodynamics of meropenem in children with severe infection",
        "Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients",
        "Pharmacokinetic and Pharmacodynamic Properties of Meropenem",
        "Optimal dosage regimen of meropenem for pediatric patients based on pharmacokinetic/pharmacodynamic considerations",
        "The pharmacokinetics of meropenem in infants and children: a population analysis",
        "Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability",
        "Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children",
        "Prognostic accuracy of age-adapted SOFA, SIRS, PELOD-2, and qSOFA for in-hospital mortality among children with suspected infection admitted to the intensive care unit",
        "Measurement and estimation of GFR in children and adolescents",
        "Population pharmacokinetics of meropenem in plasma and cerebrospinal fluid of infants with suspected or complicated intra-abdominal infections",
        "Meropenem pharmacokinetics in the newborn",
        "Reappraisal of the Optimal Dose of Meropenem in Critically Ill Infants and Children: a Developmental Pharmacokinetic-Pharmacodynamic Analysis",
        "Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis",
        "Renal function and injury in infants and young children with congenital heart disease"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}